Frequencies for first 10,000 rows of indi_pt variable in indi2009q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 2 0.02 0.02 ABDOMINAL INFECTION | 1 0.01 0.03 ABDOMINAL PAIN | 7 0.07 0.10 ABDOMINAL PAIN LOWER | 1 0.01 0.11 ABDOMINAL PAIN UPPER | 2 0.02 0.13 ABNORMAL BEHAVIOUR | 3 0.03 0.16 ABORTION INDUCED | 1 0.01 0.17 ACCIDENT AT WORK | 1 0.01 0.18 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 0.19 ACCIDENTAL EXPOSURE | 6 0.06 0.25 ACNE | 20 0.20 0.45 ACNE CONGLOBATA | 1 0.01 0.46 ACQUIRED IMMUNODEFICIENCY SYNDROME | 1 0.01 0.47 ACROMEGALY | 4 0.04 0.51 ACUTE CORONARY SYNDROME | 2 0.02 0.53 ACUTE GRAFT VERSUS HOST DISEASE | 1 0.01 0.54 ACUTE LYMPHOCYTIC LEUKAEMIA | 4 0.04 0.58 ACUTE MYELOID LEUKAEMIA | 21 0.21 0.79 ACUTE MYOCARDIAL INFARCTION | 13 0.13 0.92 ACUTE TONSILLITIS | 1 0.01 0.93 ADENOCARCINOMA | 1 0.01 0.94 ADENOCARCINOMA PANCREAS | 4 0.04 0.98 ADJUSTMENT DISORDER WITH DEPRESSED MOOD | 1 0.01 0.99 ADJUVANT THERAPY | 1 0.01 1.00 ADRENAL DISORDER | 1 0.01 1.01 ADRENOCORTICAL STEROID THERAPY | 1 0.01 1.02 ADVERSE DRUG REACTION | 2 0.02 1.04 AFFECT LABILITY | 1 0.01 1.05 AFFECTIVE DISORDER | 8 0.08 1.13 AGGRESSION | 1 0.01 1.14 AGITATION | 14 0.14 1.28 ALCOHOL DETOXIFICATION | 1 0.01 1.29 ALCOHOLIC PSYCHOSIS | 1 0.01 1.30 ALCOHOLISM | 1 0.01 1.31 ALLERGIC BRONCHITIS | 1 0.01 1.32 ALOPECIA | 2 0.02 1.34 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 1 0.01 1.35 AMNESIA | 1 0.01 1.36 AMNIOTIC CAVITY INFECTION | 1 0.01 1.37 AMYLOIDOSIS | 4 0.04 1.41 ANAEMIA | 12 0.12 1.53 ANAEMIA OF CHRONIC DISEASE | 2 0.02 1.55 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 1.56 ANAEMIA PROPHYLAXIS | 1 0.01 1.57 ANAESTHESIA | 19 0.19 1.76 ANAESTHESIA PROCEDURE | 1 0.01 1.77 ANAESTHETIC PREMEDICATION | 2 0.02 1.79 ANALGESIC INTERVENTION SUPPORTIVE THE.. | 1 0.01 1.80 ANALGESIC THERAPY | 14 0.14 1.94 ANAPHYLACTIC REACTION | 1 0.01 1.95 ANDROGENETIC ALOPECIA | 2 0.02 1.97 ANEURYSM REPAIR | 1 0.01 1.98 ANGER | 2 0.02 2.00 ANGINA PECTORIS | 10 0.10 2.10 ANGINA UNSTABLE | 1 0.01 2.11 ANGIOGRAM | 11 0.11 2.22 ANGIOGRAM RETINA | 1 0.01 2.23 ANGIOPATHY | 1 0.01 2.24 ANGLE CLOSURE GLAUCOMA | 2 0.02 2.26 ANKLE FRACTURE | 1 0.01 2.27 ANKYLOSING SPONDYLITIS | 31 0.31 2.58 ANORECTAL DISORDER | 1 0.01 2.59 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 3 0.03 2.62 ANTIALLERGIC THERAPY | 1 0.01 2.63 ANTIBIOTIC PROPHYLAXIS | 4 0.04 2.67 ANTIBIOTIC THERAPY | 9 0.09 2.76 ANTICOAGULANT THERAPY | 9 0.09 2.85 ANTIDEPRESSANT THERAPY | 1 0.01 2.86 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 2.87 ANTIFUNGAL PROPHYLAXIS | 8 0.08 2.95 ANTIINFLAMMATORY THERAPY | 1 0.01 2.96 ANTIOESTROGEN THERAPY | 1 0.01 2.97 ANTIPYRESIS | 2 0.02 2.99 ANTIRETROVIRAL THERAPY | 6 0.06 3.05 ANTITUSSIVE THERAPY | 2 0.02 3.07 ANTIVIRAL PROPHYLAXIS | 6 0.06 3.13 ANXIETY | 85 0.85 3.98 ANXIETY DISORDER | 6 0.06 4.04 AORTIC ANEURYSM | 1 0.01 4.05 APLASIA PURE RED CELL | 2 0.02 4.07 APPENDICITIS | 2 0.02 4.09 ARRHYTHMIA | 12 0.12 4.21 ARRHYTHMIA PROPHYLAXIS | 1 0.01 4.22 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 4.23 ARTERIAL THERAPEUTIC PROCEDURE | 1 0.01 4.24 ARTERIOGRAM CORONARY | 1 0.01 4.25 ARTHRALGIA | 23 0.23 4.48 ARTHRITIS | 16 0.16 4.64 ARTHROPATHY | 2 0.02 4.66 ARTHROPOD BITE | 1 0.01 4.67 ASCITES | 5 0.05 4.72 ASPERGER'S DISORDER | 1 0.01 4.73 ASPERGILLOSIS | 4 0.04 4.77 ASTEATOSIS | 1 0.01 4.78 ASTHMA | 85 0.85 5.63 ATRIAL FIBRILLATION | 27 0.27 5.90 ATROPHIC VULVOVAGINITIS | 1 0.01 5.91 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 23 0.23 6.14 AUTISM | 1 0.01 6.15 AUTISM SPECTRUM DISORDER | 2 0.02 6.17 AUTOIMMUNE HEPATITIS | 2 0.02 6.19 AUTOIMMUNE THYROIDITIS | 1 0.01 6.20 B-CELL LYMPHOMA | 24 0.24 6.44 BACK DISORDER | 1 0.01 6.45 BACK PAIN | 44 0.44 6.89 BACTERIAL INFECTION | 1 0.01 6.90 BACTERIAL PYELONEPHRITIS | 2 0.02 6.92 BASAL GANGLION DEGENERATION | 1 0.01 6.93 BEHCET'S SYNDROME | 1 0.01 6.94 BENIGN NEOPLASM OF THYROID GLAND | 1 0.01 6.95 BENIGN PROSTATIC HYPERPLASIA | 17 0.17 7.12 BILE DUCT CANCER | 1 0.01 7.13 BIPOLAR DISORDER | 51 0.51 7.64 BIPOLAR I DISORDER | 11 0.11 7.75 BIPOLAR II DISORDER | 2 0.02 7.77 BLADDER CANCER | 1 0.01 7.78 BLADDER TRANSITIONAL CELL CARCINOMA | 2 0.02 7.80 BLOOD CHOLESTEROL | 15 0.15 7.95 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 7.96 BLOOD CHOLESTEROL INCREASED | 50 0.50 8.46 BLOOD DISORDER | 2 0.02 8.48 BLOOD GLUCOSE ABNORMAL | 1 0.01 8.49 BLOOD IRON | 1 0.01 8.50 BLOOD OESTROGEN DECREASED | 1 0.01 8.51 BLOOD OESTROGEN INCREASED | 1 0.01 8.52 BLOOD PHOSPHORUS INCREASED | 1 0.01 8.53 BLOOD POTASSIUM DECREASED | 1 0.01 8.54 BLOOD PRESSURE | 45 0.45 8.99 BLOOD PRESSURE ABNORMAL | 3 0.03 9.02 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 9.04 BLOOD PRESSURE INCREASED | 7 0.07 9.11 BLOOD PRESSURE MANAGEMENT | 2 0.02 9.13 BLOOD PRODUCT TRANSFUSION | 1 0.01 9.14 BLOOD TEST | 2 0.02 9.16 BLOOD TESTOSTERONE ABNORMAL | 1 0.01 9.17 BLOOD TESTOSTERONE DECREASED | 1 0.01 9.18 BLOOD TRIGLYCERIDES | 1 0.01 9.19 BLOOD TRIGLYCERIDES INCREASED | 3 0.03 9.22 BODY TEMPERATURE INCREASED | 2 0.02 9.24 BONE DENSITY ABNORMAL | 1 0.01 9.25 BONE DISORDER | 4 0.04 9.29 BONE MARROW CONDITIONING REGIMEN | 2 0.02 9.31 BONE PAIN | 7 0.07 9.38 BONE SARCOMA | 2 0.02 9.40 BOWEL PREPARATION | 1 0.01 9.41 BRAIN ABSCESS | 2 0.02 9.43 BRAIN NEOPLASM | 1 0.01 9.44 BREAKTHROUGH PAIN | 4 0.04 9.48 BREAST CANCER | 533 5.33 14.81 BREAST CANCER FEMALE | 123 1.23 16.04 BREAST CANCER IN SITU | 1 0.01 16.05 BREAST CANCER METASTATIC | 25 0.25 16.30 BREAST CANCER RECURRENT | 5 0.05 16.35 BREAST CANCER STAGE I | 15 0.15 16.50 BREAST CANCER STAGE II | 5 0.05 16.55 BREAST CANCER STAGE III | 3 0.03 16.58 BREAST CANCER STAGE IV | 1 0.01 16.59 BREAST FEEDING | 1 0.01 16.60 BREAST LUMP REMOVAL | 1 0.01 16.61 BRONCHIECTASIS | 2 0.02 16.63 BRONCHITIS | 18 0.18 16.81 BRONCHITIS CHRONIC | 2 0.02 16.83 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 16.85 BRONCHOSCOPY | 1 0.01 16.86 BRONCHOSPASM | 1 0.01 16.87 BURKITT'S LYMPHOMA | 2 0.02 16.89 CANCER PAIN | 10 0.10 16.99 CANDIDIASIS | 2 0.02 17.01 CARCINOID SYNDROME | 2 0.02 17.03 CARCINOID TUMOUR | 8 0.08 17.11 CARDIAC DISORDER | 23 0.23 17.34 CARDIAC FAILURE | 17 0.17 17.51 CARDIAC FAILURE CHRONIC | 3 0.03 17.54 CARDIAC FAILURE CONGESTIVE | 13 0.13 17.67 CARDIAC OPERATION | 5 0.05 17.72 CARDIAC REHABILITATION THERAPY | 2 0.02 17.74 CARDIOVASCULAR DISORDER | 11 0.11 17.85 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 17.89 CARPAL TUNNEL SYNDROME | 1 0.01 17.90 CATHETERISATION CARDIAC | 3 0.03 17.93 CELLULITIS | 4 0.04 17.97 CENTRAL VENOUS CATHETERISATION | 1 0.01 17.98 CEREBRAL DISORDER | 1 0.01 17.99 CEREBRAL HAEMATOMA | 1 0.01 18.00 CEREBRAL HAEMORRHAGE | 1 0.01 18.01 CEREBRAL INFARCTION | 3 0.03 18.04 CEREBRAL NEUROBLASTOMA | 1 0.01 18.05 CEREBROVASCULAR ACCIDENT | 6 0.06 18.11 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 1 0.01 18.12 CERVIX CARCINOMA RECURRENT | 2 0.02 18.14 CHEILITIS | 3 0.03 18.17 CHEMOTHERAPY | 18 0.18 18.35 CHEST PAIN | 6 0.06 18.41 CHOLANGITIS | 1 0.01 18.42 CHOLECYSTITIS ACUTE | 1 0.01 18.43 CHROMOSOME ANALYSIS ABNORMAL | 1 0.01 18.44 CHRONIC GRAFT VERSUS HOST DISEASE | 1 0.01 18.45 CHRONIC LYMPHOCYTIC LEUKAEMIA | 20 0.20 18.65 CHRONIC MYELOID LEUKAEMIA | 21 0.21 18.86 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 85 0.85 19.71 COAGULOPATHY | 1 0.01 19.72 COLITIS | 2 0.02 19.74 COLITIS ULCERATIVE | 28 0.28 20.02 COLON CANCER | 10 0.10 20.12 COLON CANCER METASTATIC | 3 0.03 20.15 COLONOSCOPY | 6 0.06 20.21 COLORECTAL CANCER | 24 0.24 20.45 COLORECTAL CANCER METASTATIC | 24 0.24 20.69 COMPUTERISED TOMOGRAM | 3 0.03 20.72 COMPUTERISED TOMOGRAM ABDOMEN | 2 0.02 20.74 CONCOMITANT DISEASE AGGRAVATED | 3 0.03 20.77 CONJUNCTIVITIS | 1 0.01 20.78 CONSTIPATION | 28 0.28 21.06 CONSTIPATION PROPHYLAXIS | 4 0.04 21.10 CONTRACEPTION | 132 1.32 22.42 CONVULSION | 22 0.22 22.64 CONVULSION PROPHYLAXIS | 4 0.04 22.68 COORDINATION ABNORMAL | 1 0.01 22.69 CORD BLOOD TRANSPLANT THERAPY | 7 0.07 22.76 CORONARY ARTERIAL STENT INSERTION | 4 0.04 22.80 CORONARY ARTERY BYPASS | 4 0.04 22.84 CORONARY ARTERY DISEASE | 13 0.13 22.97 COUGH | 9 0.09 23.06 CRANIOTOMY | 1 0.01 23.07 CROHN'S DISEASE | 77 0.77 23.84 CUTANEOUS LEISHMANIASIS | 3 0.03 23.87 CYCLOPLEGIC REFRACTION | 1 0.01 23.88 CYSTITIS | 1 0.01 23.89 CYSTITIS INTERSTITIAL | 2 0.02 23.91 CYSTOSCOPY | 1 0.01 23.92 CYTOMEGALOVIRUS INFECTION | 2 0.02 23.94 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 23.95 DEAFNESS UNILATERAL | 1 0.01 23.96 DEEP VEIN THROMBOSIS | 13 0.13 24.09 DEHYDRATION | 7 0.07 24.16 DELIRIUM | 2 0.02 24.18 DEMENTIA | 6 0.06 24.24 DEMENTIA ALZHEIMER'S TYPE | 20 0.20 24.44 DENTAL CARE | 1 0.01 24.45 DENTAL DISORDER PROPHYLAXIS | 2 0.02 24.47 DEPRESSED MOOD | 5 0.05 24.52 DEPRESSION | 173 1.73 26.25 DEPRESSIVE SYMPTOM | 2 0.02 26.27 DERMATITIS | 6 0.06 26.33 DERMATITIS ATOPIC | 1 0.01 26.34 DERMATOMYOSITIS | 4 0.04 26.38 DERMO-HYPODERMITIS | 1 0.01 26.39 DIABETES MELLITUS | 105 1.05 27.44 DIABETIC NEUROPATHY | 6 0.06 27.50 DIAGNOSTIC PROCEDURE | 1 0.01 27.51 DIALYSIS | 9 0.09 27.60 DIARRHOEA | 12 0.12 27.72 DIFFUSE ALVEOLAR DAMAGE | 6 0.06 27.78 DIFFUSE LARGE B-CELL LYMPHOMA | 68 0.68 28.46 DIURETIC THERAPY | 2 0.02 28.48 DIVERTICULITIS | 1 0.01 28.49 DIZZINESS | 3 0.03 28.52 DRUG DEPENDENCE | 2 0.02 28.54 DRUG ERUPTION | 8 0.08 28.62 DRUG EXPOSURE DURING PREGNANCY | 36 0.36 28.98 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 28.99 DRUG TOXICITY PROPHYLAXIS | 1 0.01 29.00 DRUG USE FOR UNKNOWN INDICATION | 1,986 19.86 48.86 DRY EYE | 3 0.03 48.89 DUODENAL ULCER | 1 0.01 48.90 DYSKINESIA | 1 0.01 48.91 DYSKINESIA OESOPHAGEAL | 1 0.01 48.92 DYSLIPIDAEMIA | 8 0.08 49.00 DYSMENORRHOEA | 5 0.05 49.05 DYSPEPSIA | 10 0.10 49.15 DYSPHAGIA | 1 0.01 49.16 DYSPNOEA | 12 0.12 49.28 DYSTHYMIC DISORDER | 9 0.09 49.37 DYSURIA | 1 0.01 49.38 EAR DISORDER | 1 0.01 49.39 EAR INFECTION | 2 0.02 49.41 ECZEMA | 1 0.01 49.42 ECZEMA ASTEATOTIC | 2 0.02 49.44 EMBOLISM | 2 0.02 49.46 EMPHYSEMA | 20 0.20 49.66 ENCEPHALITIS | 1 0.01 49.67 ENDOCARDITIS | 1 0.01 49.68 ENDOMETRIOSIS | 5 0.05 49.73 ENDOSCOPY LARGE BOWEL | 2 0.02 49.75 ENTEROCOCCAL BACTERAEMIA | 1 0.01 49.76 EPIDURAL ANAESTHESIA | 2 0.02 49.78 EPILEPSY | 63 0.63 50.41 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 6 0.06 50.47 ERECTILE DYSFUNCTION | 12 0.12 50.59 ERYSIPELAS | 3 0.03 50.62 ESSENTIAL HYPERTENSION | 13 0.13 50.75 EUPHORIC MOOD | 1 0.01 50.76 EVIDENCE BASED TREATMENT | 1 0.01 50.77 EX-TOBACCO USER | 1 0.01 50.78 EXTRAPYRAMIDAL DISORDER | 1 0.01 50.79 EYE DISORDER | 3 0.03 50.82 EYE IRRITATION | 1 0.01 50.83 EYELID INFECTION | 1 0.01 50.84 FABRY'S DISEASE | 1 0.01 50.85 FACIAL PALSY | 5 0.05 50.90 FACIAL SPASM | 2 0.02 50.92 FACTOR VIII DEFICIENCY | 1 0.01 50.93 FATIGUE | 3 0.03 50.96 FEBRILE NEUTROPENIA | 5 0.05 51.01 FEMUR FRACTURE | 1 0.01 51.02 FIBROMUSCULAR DYSPLASIA | 1 0.01 51.03 FIBROMYALGIA | 15 0.15 51.18 FLATULENCE | 4 0.04 51.22 FLUID OVERLOAD | 1 0.01 51.23 FLUID REPLACEMENT | 3 0.03 51.26 FLUID RETENTION | 2 0.02 51.28 FOLATE DEFICIENCY | 1 0.01 51.29 FUNGAL INFECTION | 4 0.04 51.33 FURUNCLE | 1 0.01 51.34 GAMMA RADIATION THERAPY TO BREAST | 2 0.02 51.36 GASTRIC BYPASS | 1 0.01 51.37 GASTRIC CANCER | 16 0.16 51.53 GASTRIC DISORDER | 5 0.05 51.58 GASTRIC PH DECREASED | 1 0.01 51.59 GASTRIC ULCER | 13 0.13 51.72 GASTRINOMA | 1 0.01 51.73 GASTRITIS | 11 0.11 51.84 GASTRITIS EROSIVE | 1 0.01 51.85 GASTRITIS PROPHYLAXIS | 7 0.07 51.92 GASTRODUODENITIS | 1 0.01 51.93 GASTROINTESTINAL DISORDER | 7 0.07 52.00 GASTROINTESTINAL HAEMORRHAGE | 7 0.07 52.07 GASTROINTESTINAL HYPERMOTILITY | 1 0.01 52.08 GASTROINTESTINAL INFECTION | 1 0.01 52.09 GASTROINTESTINAL STOMA COMPLICATION | 2 0.02 52.11 GASTROINTESTINAL STROMAL TUMOUR | 8 0.08 52.19 GASTROINTESTINAL ULCER | 1 0.01 52.20 GASTROOESOPHAGEAL CANCER | 9 0.09 52.29 GASTROOESOPHAGEAL REFLUX DISEASE | 54 0.54 52.83 GAUCHER'S DISEASE | 2 0.02 52.85 GENERAL ANAESTHESIA | 6 0.06 52.91 GENERALISED ANXIETY DISORDER | 1 0.01 52.92 GESTATIONAL DIABETES | 2 0.02 52.94 GESTATIONAL TROPHOBLASTIC TUMOUR | 5 0.05 52.99 GLAUCOMA | 18 0.18 53.17 GLIOBLASTOMA | 3 0.03 53.20 GLIOBLASTOMA MULTIFORME | 7 0.07 53.27 GLIOMA | 1 0.01 53.28 GLOMERULONEPHRITIS | 5 0.05 53.33 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 53.34 GLOSSITIS | 1 0.01 53.35 GLUCOSE TOLERANCE IMPAIRED | 5 0.05 53.40 GOODPASTURE'S SYNDROME | 4 0.04 53.44 GOUT | 5 0.05 53.49 GRAFT VERSUS HOST DISEASE | 1 0.01 53.50 GRAND MAL CONVULSION | 1 0.01 53.51 GROIN PAIN | 1 0.01 53.52 GROWTH RETARDATION | 1 0.01 53.53 HAEMATOCHEZIA | 1 0.01 53.54 HAEMOCHROMATOSIS | 2 0.02 53.56 HAEMODIALYSIS | 2 0.02 53.58 HAEMOGLOBIN | 1 0.01 53.59 HAEMOGLOBIN C DISEASE | 1 0.01 53.60 HAEMOPHILIA A WITH ANTI FACTOR VIII | 1 0.01 53.61 HAEMORRHAGE PROPHYLAXIS | 2 0.02 53.63 HAEMORRHOIDS | 2 0.02 53.65 HAEMOSIDEROSIS | 3 0.03 53.68 HAEMOSTASIS | 2 0.02 53.70 HAIRY CELL LEUKAEMIA | 2 0.02 53.72 HALLUCINATION | 1 0.01 53.73 HALLUCINATION, AUDITORY | 1 0.01 53.74 HEAD AND NECK CANCER | 9 0.09 53.83 HEAD TITUBATION | 1 0.01 53.84 HEADACHE | 18 0.18 54.02 HEARING IMPAIRED | 1 0.01 54.03 HEART DISEASE CONGENITAL | 1 0.01 54.04 HEART RATE | 1 0.01 54.05 HEART RATE INCREASED | 3 0.03 54.08 HEART RATE IRREGULAR | 1 0.01 54.09 HEART TRANSPLANT | 5 0.05 54.14 HELICOBACTER INFECTION | 6 0.06 54.20 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 54.21 HEPATIC CANCER METASTATIC | 1 0.01 54.22 HEPATIC CANCER STAGE IV | 1 0.01 54.23 HEPATIC ENZYME INCREASED | 1 0.01 54.24 HEPATIC FUNCTION ABNORMAL | 2 0.02 54.26 HEPATIC HAEMORRHAGE | 1 0.01 54.27 HEPATIC NEOPLASM | 1 0.01 54.28 HEPATIC NEOPLASM MALIGNANT | 21 0.21 54.49 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 2 0.02 54.51 HEPATITIS | 2 0.02 54.53 HEPATITIS B | 6 0.06 54.59 HEPATITIS B IMMUNISATION | 1 0.01 54.60 HEPATITIS C | 43 0.43 55.03 HERNIA REPAIR | 1 0.01 55.04 HERPES ZOSTER | 2 0.02 55.06 HIATUS HERNIA | 1 0.01 55.07 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 55.08 HIP FRACTURE | 1 0.01 55.09 HISTOPLASMOSIS | 2 0.02 55.11 HIV INFECTION | 174 1.74 56.85 HIV TEST POSITIVE | 4 0.04 56.89 HODGKIN'S DISEASE | 11 0.11 57.00 HODGKIN'S DISEASE REFRACTORY | 10 0.10 57.10 HORMONE LEVEL ABNORMAL | 1 0.01 57.11 HORMONE REPLACEMENT THERAPY | 81 0.81 57.92 HORMONE THERAPY | 1 0.01 57.93 HOT FLUSH | 3 0.03 57.96 HUMERUS FRACTURE | 1 0.01 57.97 HYPERCALCAEMIA | 3 0.03 58.00 HYPERCHLORHYDRIA | 3 0.03 58.03 HYPERCHOLESTEROLAEMIA | 17 0.17 58.20 HYPERGLYCAEMIA | 2 0.02 58.22 HYPERKALAEMIA | 6 0.06 58.28 HYPERLIPIDAEMIA | 24 0.24 58.52 HYPERPARATHYROIDISM SECONDARY | 5 0.05 58.57 HYPERPHOSPHATAEMIA | 2 0.02 58.59 HYPERSENSITIVITY | 26 0.26 58.85 HYPERTENSION | 384 3.84 62.69 HYPERTHYROIDISM | 5 0.05 62.74 HYPERTONIA | 1 0.01 62.75 HYPERTONIC BLADDER | 9 0.09 62.84 HYPERURICAEMIA | 7 0.07 62.91 HYPERVENTILATION | 1 0.01 62.92 HYPERVIGILANCE | 1 0.01 62.93 HYPOALBUMINAEMIA | 1 0.01 62.94 HYPOGONADISM | 1 0.01 62.95 HYPOKALAEMIA | 2 0.02 62.97 HYPOPITUITARISM | 1 0.01 62.98 HYPOPROTEINAEMIA | 1 0.01 62.99 HYPOTENSION | 4 0.04 63.03 HYPOTHYROIDISM | 46 0.46 63.49 HYPOTONIA | 1 0.01 63.50 HYPOVOLAEMIA | 2 0.02 63.52 HYSTERECTOMY | 2 0.02 63.54 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 21 0.21 63.75 ILL-DEFINED DISORDER | 2 0.02 63.77 IMMUNE ENHANCEMENT THERAPY | 1 0.01 63.78 IMMUNE SYSTEM DISORDER | 1 0.01 63.79 IMMUNISATION | 7 0.07 63.86 IMMUNOSUPPRESSION | 47 0.47 64.33 IMPULSE-CONTROL DISORDER | 1 0.01 64.34 INCONTINENCE | 1 0.01 64.35 INCREASED APPETITE | 1 0.01 64.36 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 2 0.02 64.38 INFECTION | 8 0.08 64.46 INFECTION PROPHYLAXIS | 17 0.17 64.63 INFERTILITY | 1 0.01 64.64 INFILTRATION ANAESTHESIA | 1 0.01 64.65 INFLAMMATION | 2 0.02 64.67 INFLAMMATORY BOWEL DISEASE | 5 0.05 64.72 INFLAMMATORY CARCINOMA OF THE BREAST | 1 0.01 64.73 INFLUENZA | 18 0.18 64.91 INFLUENZA IMMUNISATION | 1 0.01 64.92 INFLUENZA LIKE ILLNESS | 1 0.01 64.93 INHIBITING ANTIBODIES | 1 0.01 64.94 INITIAL INSOMNIA | 1 0.01 64.95 INJECTION | 2 0.02 64.97 INJECTION SITE ERYTHEMA | 1 0.01 64.98 INJECTION SITE REACTION | 1 0.01 64.99 INJURY | 1 0.01 65.00 INSOMNIA | 62 0.62 65.62 INSULIN-LIKE GROWTH FACTOR INCREASED | 1 0.01 65.63 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 8 0.08 65.71 INTENTIONAL DRUG MISUSE | 1 0.01 65.72 INTENTIONAL OVERDOSE | 1 0.01 65.73 INTERTRIGO CANDIDA | 1 0.01 65.74 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 65.75 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 65.79 INTESTINAL OBSTRUCTION | 1 0.01 65.80 INTESTINAL TRANSPLANT | 2 0.02 65.82 INTRAOCULAR PRESSURE INCREASED | 3 0.03 65.85 INTRAOCULAR PRESSURE TEST | 1 0.01 65.86 INTRAOCULAR PRESSURE TEST ABNORMAL | 2 0.02 65.88 INTRAVENOUS CATHETER MANAGEMENT | 3 0.03 65.91 IRON DEFICIENCY | 3 0.03 65.94 IRON DEFICIENCY ANAEMIA | 1 0.01 65.95 IRON METABOLISM DISORDER | 1 0.01 65.96 IRON OVERLOAD | 11 0.11 66.07 IRRITABLE BOWEL SYNDROME | 3 0.03 66.10 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 4 0.04 66.14 JOINT SWELLING | 1 0.01 66.15 JUGULAR VEIN THROMBOSIS | 1 0.01 66.16 JUVENILE ARTHRITIS | 6 0.06 66.22 KETOACIDOSIS | 1 0.01 66.23 KIDNEY TRANSPLANT REJECTION | 1 0.01 66.24 LABOUR PAIN | 2 0.02 66.26 LABYRINTHITIS | 4 0.04 66.30 LACUNAR INFARCTION | 2 0.02 66.32 LARGE INTESTINE CARCINOMA | 1 0.01 66.33 LARYNGITIS | 1 0.01 66.34 LATEX ALLERGY | 1 0.01 66.35 LAXATIVE SUPPORTIVE CARE | 1 0.01 66.36 LEFT VENTRICULAR HYPERTROPHY | 1 0.01 66.37 LENNOX-GASTAUT SYNDROME | 1 0.01 66.38 LEUKAEMIA | 1 0.01 66.39 LEUKOCYTOSIS | 1 0.01 66.40 LEUKOENCEPHALOPATHY | 1 0.01 66.41 LIPID METABOLISM DISORDER | 1 0.01 66.42 LIPIDS ABNORMAL | 1 0.01 66.43 LIPIDS INCREASED | 2 0.02 66.45 LIPODYSTROPHY ACQUIRED | 1 0.01 66.46 LIVER DISORDER | 6 0.06 66.52 LIVER TRANSPLANT | 17 0.17 66.69 LOCAL ANAESTHESIA | 2 0.02 66.71 LOSS OF CONSCIOUSNESS | 1 0.01 66.72 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 66.73 LOWER RESPIRATORY TRACT INFECTION | 4 0.04 66.77 LUNG ADENOCARCINOMA | 6 0.06 66.83 LUNG CANCER METASTATIC | 2 0.02 66.85 LUNG DISORDER | 3 0.03 66.88 LUNG INFECTION | 7 0.07 66.95 LUNG NEOPLASM MALIGNANT | 15 0.15 67.10 LUNG SQUAMOUS CELL CARCINOMA STAGE IV | 1 0.01 67.11 LUPUS NEPHRITIS | 3 0.03 67.14 LUTEAL PHASE DEFICIENCY | 1 0.01 67.15 LYMPHOMA | 8 0.08 67.23 MACULAR DEGENERATION | 9 0.09 67.32 MACULAR OEDEMA | 4 0.04 67.36 MAGNESIUM DEFICIENCY | 1 0.01 67.37 MAJOR DEPRESSION | 13 0.13 67.50 MALAISE | 1 0.01 67.51 MALARIA | 1 0.01 67.52 MALARIA PROPHYLAXIS | 2 0.02 67.54 MALE SEXUAL DYSFUNCTION | 1 0.01 67.55 MALIGNANT LYMPHOID NEOPLASM | 5 0.05 67.60 MALIGNANT MELANOMA | 5 0.05 67.65 MALNUTRITION | 3 0.03 67.68 MANIA | 5 0.05 67.73 MANTLE CELL LYMPHOMA | 13 0.13 67.86 MASTECTOMY | 1 0.01 67.87 MENINGITIS | 2 0.02 67.89 MENINGOENCEPHALITIS BACTERIAL | 2 0.02 67.91 MENOPAUSAL SYMPTOMS | 11 0.11 68.02 MENOPAUSE | 7 0.07 68.09 MENORRHAGIA | 1 0.01 68.10 MENSTRUAL DISCOMFORT | 3 0.03 68.13 MENSTRUAL DISORDER | 2 0.02 68.15 MENSTRUATION IRREGULAR | 3 0.03 68.18 MENTAL DISORDER | 7 0.07 68.25 MESANGIOPROLIFERATIVE GLOMERULONEPHRI.. | 3 0.03 68.28 METASTASES TO BONE | 1 0.01 68.29 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 68.30 METASTASES TO EYE | 2 0.02 68.32 METASTASES TO LIVER | 1 0.01 68.33 METASTASES TO LUNG | 3 0.03 68.36 METASTASIS | 3 0.03 68.39 METASTATIC CARCINOID TUMOUR | 1 0.01 68.40 METASTATIC GASTRIC CANCER | 6 0.06 68.46 METASTATIC MALIGNANT MELANOMA | 6 0.06 68.52 METASTATIC NEOPLASM | 2 0.02 68.54 METASTATIC RENAL CELL CARCINOMA | 13 0.13 68.67 MIGRAINE | 15 0.15 68.82 MIGRAINE PROPHYLAXIS | 2 0.02 68.84 MINERAL SUPPLEMENTATION | 1 0.01 68.85 MITRAL VALVE DISEASE | 1 0.01 68.86 MITRAL VALVE PROLAPSE | 1 0.01 68.87 MOOD ALTERED | 1 0.01 68.88 MOOD SWINGS | 5 0.05 68.93 MOTOR DYSFUNCTION | 2 0.02 68.95 MOUTH ULCERATION | 1 0.01 68.96 MOVEMENT DISORDER | 1 0.01 68.97 MUCOSAL INFLAMMATION | 1 0.01 68.98 MULTI-ORGAN FAILURE | 1 0.01 68.99 MULTIPLE ALLERGIES | 13 0.13 69.12 MULTIPLE MYELOMA | 99 0.99 70.11 MULTIPLE SCLEROSIS | 264 2.64 72.75 MUSCLE CONTRACTURE | 3 0.03 72.78 MUSCLE RELAXANT THERAPY | 1 0.01 72.79 MUSCLE RUPTURE | 5 0.05 72.84 MUSCLE SPASMS | 14 0.14 72.98 MUSCLE SPASTICITY | 22 0.22 73.20 MUSCLE STRAIN | 1 0.01 73.21 MUSCULOSKELETAL PAIN | 27 0.27 73.48 MYALGIA | 5 0.05 73.53 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 73.54 MYDRIASIS | 2 0.02 73.56 MYELODYSPLASTIC SYNDROME | 21 0.21 73.77 MYELOFIBROSIS | 1 0.01 73.78 MYOCARDIAL INFARCTION | 13 0.13 73.91 NARCOLEPSY | 1 0.01 73.92 NASAL CONGESTION | 5 0.05 73.97 NASAL DISORDER | 1 0.01 73.98 NASAL DRYNESS | 1 0.01 73.99 NASOPHARYNGITIS | 18 0.18 74.17 NAUSEA | 29 0.29 74.46 NECK INJURY | 1 0.01 74.47 NECK PAIN | 3 0.03 74.50 NEONATAL ASPIRATION | 2 0.02 74.52 NEOPLASM | 2 0.02 74.54 NEOPLASM MALIGNANT | 21 0.21 74.75 NEPHRITIS | 1 0.01 74.76 NEPHROLITHIASIS | 2 0.02 74.78 NEPHROPATHY | 1 0.01 74.79 NEPHROTIC SYNDROME | 1 0.01 74.80 NERVE BLOCK | 2 0.02 74.82 NERVOUS SYSTEM DISORDER | 3 0.03 74.85 NERVOUSNESS | 1 0.01 74.86 NEURALGIA | 19 0.19 75.05 NEURITIS | 1 0.01 75.06 NEUROBLASTOMA | 2 0.02 75.08 NEUROENDOCRINE TUMOUR | 4 0.04 75.12 NEUROGENIC BLADDER | 5 0.05 75.17 NEUROPATHY PERIPHERAL | 12 0.12 75.29 NEUTROPENIA | 5 0.05 75.34 NEUTROPHIL COUNT DECREASED | 1 0.01 75.35 NIGHTMARE | 1 0.01 75.36 NON-HODGKIN'S LYMPHOMA | 22 0.22 75.58 NON-HODGKIN'S LYMPHOMA UNSPECIFIED HI.. | 5 0.05 75.63 NON-SMALL CELL LUNG CANCER | 78 0.78 76.41 NON-SMALL CELL LUNG CANCER METASTATIC | 10 0.10 76.51 NON-SMALL CELL LUNG CANCER STAGE III | 2 0.02 76.53 NUCLEAR MAGNETIC RESONANCE IMAGING | 25 0.25 76.78 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 2 0.02 76.80 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 6 0.06 76.86 NUTRITIONAL SUPPORT | 2 0.02 76.88 OBESITY | 2 0.02 76.90 OCCUPATIONAL EXPOSURE TO DRUG | 1 0.01 76.91 OCULAR HYPERTENSION | 2 0.02 76.93 OEDEMA | 8 0.08 77.01 OEDEMA PERIPHERAL | 1 0.01 77.02 OESOPHAGEAL CARCINOMA | 2 0.02 77.04 OESOPHAGITIS | 2 0.02 77.06 OESTROGEN REPLACEMENT THERAPY | 2 0.02 77.08 OFF LABEL USE | 3 0.03 77.11 ONYCHOMYCOSIS | 3 0.03 77.14 OPEN ANGLE GLAUCOMA | 1 0.01 77.15 OPERATIVE HAEMORRHAGE | 1 0.01 77.16 OPHTHALMIA NEONATORUM | 2 0.02 77.18 OPSOCLONUS MYOCLONUS | 1 0.01 77.19 OPTIC NEURITIS | 1 0.01 77.20 ORAL CANDIDIASIS | 2 0.02 77.22 ORAL CONTRACEPTION | 3 0.03 77.25 ORAL HERPES | 1 0.01 77.26 ORGAN TRANSPLANT | 2 0.02 77.28 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 2 0.02 77.30 OROPHARYNGEAL PAIN | 3 0.03 77.33 ORTHOSTATIC HYPOTENSION | 2 0.02 77.35 OSTEITIS DEFORMANS | 2 0.02 77.37 OSTEOARTHRITIS | 22 0.22 77.59 OSTEOLYSIS | 1 0.01 77.60 OSTEOMYELITIS | 2 0.02 77.62 OSTEOPENIA | 22 0.22 77.84 OSTEOPOROSIS | 154 1.54 79.38 OSTEOPOROSIS POSTMENOPAUSAL | 1 0.01 79.39 OSTEOPOROSIS PROPHYLAXIS | 10 0.10 79.49 OTITIS MEDIA | 2 0.02 79.51 OTITIS MEDIA ACUTE | 7 0.07 79.58 OVARIAN CANCER | 10 0.10 79.68 OVARIAN CANCER METASTATIC | 1 0.01 79.69 OVARIAN CANCER RECURRENT | 3 0.03 79.72 OVARIAN EPITHELIAL CANCER | 3 0.03 79.75 OVARIAN NEOPLASM | 2 0.02 79.77 PACKED RED BLOOD CELL TRANSFUSION | 4 0.04 79.81 PAIN | 150 1.50 81.31 PAIN IN EXTREMITY | 4 0.04 81.35 PAIN MANAGEMENT | 3 0.03 81.38 PALPITATIONS | 1 0.01 81.39 PANCREATIC CARCINOMA | 9 0.09 81.48 PANCREATIC CARCINOMA METASTATIC | 4 0.04 81.52 PANCREATIC MASS | 1 0.01 81.53 PANCREATIC NEUROENDOCRINE TUMOUR | 8 0.08 81.61 PANCREATITIS | 1 0.01 81.62 PANCREATITIS CHRONIC | 1 0.01 81.63 PANCREATOLITHIASIS | 1 0.01 81.64 PANCYTOPENIA | 1 0.01 81.65 PANIC ATTACK | 3 0.03 81.68 PANIC DISORDER | 4 0.04 81.72 PARALYSIS | 2 0.02 81.74 PARENTERAL NUTRITION | 1 0.01 81.75 PARKINSON'S DISEASE | 55 0.55 82.30 PARKINSONIAN REST TREMOR | 1 0.01 82.31 PARKINSONISM | 1 0.01 82.32 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 9 0.09 82.41 PARTIAL SEIZURES | 7 0.07 82.48 PATERNAL DRUGS AFFECTING FOETUS | 4 0.04 82.52 PELVIC INFLAMMATORY DISEASE | 2 0.02 82.54 PELVIC PAIN | 1 0.01 82.55 PEMPHIGUS | 1 0.01 82.56 PEPTIC ULCER | 5 0.05 82.61 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 82.63 PERIODONTAL DISEASE | 2 0.02 82.65 PERIPHERAL BLOOD STEM CELL APHERESIS | 2 0.02 82.67 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIE.. | 2 0.02 82.69 PERIPHERAL VASCULAR DISORDER | 2 0.02 82.71 PERITONEAL DIALYSIS | 86 0.86 83.57 PETIT MAL EPILEPSY | 1 0.01 83.58 PEUTZ-JEGHERS SYNDROME | 1 0.01 83.59 PHARYNGEAL INFLAMMATION | 1 0.01 83.60 PHARYNGITIS | 1 0.01 83.61 PITUITARY TUMOUR BENIGN | 1 0.01 83.62 PLASMACYTOMA | 2 0.02 83.64 PLATELET AGGREGATION | 1 0.01 83.65 PLATELET AGGREGATION INHIBITION | 1 0.01 83.66 PLATELET TRANSFUSION | 4 0.04 83.70 PNEUMOCOCCAL SEPSIS | 2 0.02 83.72 PNEUMOCYSTIS JIROVECI PNEUMONIA | 1 0.01 83.73 PNEUMONIA | 23 0.23 83.96 PNEUMONIA ASPIRATION | 4 0.04 84.00 PNEUMONIA CYTOMEGALOVIRAL | 1 0.01 84.01 PNEUMONIA STREPTOCOCCAL | 2 0.02 84.03 PNEUMONITIS | 2 0.02 84.05 POISONING | 3 0.03 84.08 POLLAKIURIA | 3 0.03 84.11 POLYMYALGIA RHEUMATICA | 1 0.01 84.12 POLYMYOSITIS | 1 0.01 84.13 POLYNEUROPATHY | 3 0.03 84.16 POLYURIA | 2 0.02 84.18 POST COITAL CONTRACEPTION | 4 0.04 84.22 POST HERPETIC NEURALGIA | 2 0.02 84.24 POST LAMINECTOMY SYNDROME | 1 0.01 84.25 POST PROCEDURAL INFECTION | 1 0.01 84.26 POST-TRAUMATIC STRESS DISORDER | 8 0.08 84.34 POSTMENOPAUSE | 1 0.01 84.35 POSTOPERATIVE ANALGESIA | 1 0.01 84.36 POSTOPERATIVE CARE | 3 0.03 84.39 POSTPARTUM STATE | 1 0.01 84.40 PREGNANCY | 2 0.02 84.42 PREMATURE MENOPAUSE | 1 0.01 84.43 PREMEDICATION | 15 0.15 84.58 PREMENSTRUAL SYNDROME | 1 0.01 84.59 PROBIOTIC THERAPY | 1 0.01 84.60 PROCEDURAL PAIN | 6 0.06 84.66 PROCTALGIA | 1 0.01 84.67 PRODUCTIVE COUGH | 3 0.03 84.70 PROLACTINOMA | 1 0.01 84.71 PROPHYLAXIS | 80 0.80 85.51 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 9 0.09 85.60 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 4 0.04 85.64 PROPHYLAXIS AGAINST HIV INFECTION | 2 0.02 85.66 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 13 0.13 85.79 PROPHYLAXIS OF NAUSEA AND VOMITING | 3 0.03 85.82 PROPHYLAXIS URINARY TRACT INFECTION | 3 0.03 85.85 PROSTATE CANCER | 25 0.25 86.10 PROSTATE CANCER METASTATIC | 1 0.01 86.11 PROSTATE CANCER STAGE II | 3 0.03 86.14 PROSTATE CANCER STAGE III | 1 0.01 86.15 PROSTATE CANCER STAGE IV | 13 0.13 86.28 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 86.29 PROSTATISM | 1 0.01 86.30 PROSTATITIS | 2 0.02 86.32 PROSTATOMEGALY | 4 0.04 86.36 PROTEINURIA | 1 0.01 86.37 PRURITUS | 2 0.02 86.39 PSEUDOMONAS INFECTION | 2 0.02 86.41 PSORIASIS | 39 0.39 86.80 PSORIATIC ARTHROPATHY | 24 0.24 87.04 PSYCHIATRIC SYMPTOM | 1 0.01 87.05 PSYCHOTIC BEHAVIOUR | 2 0.02 87.07 PSYCHOTIC DISORDER | 27 0.27 87.34 PULMONARY ARTERIAL HYPERTENSION | 15 0.15 87.49 PULMONARY EMBOLISM | 13 0.13 87.62 PULMONARY FIBROSIS | 3 0.03 87.65 PULMONARY HYPERTENSION | 5 0.05 87.70 PULMONARY TUBERCULOSIS | 4 0.04 87.74 PUSTULAR PSORIASIS | 5 0.05 87.79 PYOTHORAX | 1 0.01 87.80 PYREXIA | 43 0.43 88.23 RASH | 3 0.03 88.26 RECTAL CANCER | 18 0.18 88.44 RECTAL CANCER METASTATIC | 2 0.02 88.46 RECTAL CANCER STAGE IV | 1 0.01 88.47 RECURRENT CANCER | 1 0.01 88.48 REFLUX GASTRITIS | 1 0.01 88.49 REFLUX OESOPHAGITIS | 4 0.04 88.53 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 15 0.15 88.68 RENAL ABSCESS | 2 0.02 88.70 RENAL CANCER | 3 0.03 88.73 RENAL CANCER METASTATIC | 2 0.02 88.75 RENAL CELL CARCINOMA | 36 0.36 89.11 RENAL CELL CARCINOMA STAGE IV | 6 0.06 89.17 RENAL DISORDER | 1 0.01 89.18 RENAL FAILURE | 3 0.03 89.21 RENAL FAILURE CHRONIC | 17 0.17 89.38 RENAL TRANSPLANT | 63 0.63 90.01 RENAL VEIN THROMBOSIS | 2 0.02 90.03 RESIDUAL URINE | 2 0.02 90.05 RESPIRATORY DISORDER | 4 0.04 90.09 RESPIRATORY TRACT INFECTION | 3 0.03 90.12 RESTLESS LEGS SYNDROME | 19 0.19 90.31 RESTLESSNESS | 7 0.07 90.38 RETINAL DEPIGMENTATION | 1 0.01 90.39 RHEUMATOID ARTHRITIS | 267 2.67 93.06 RHINITIS | 2 0.02 93.08 RHINITIS ALLERGIC | 5 0.05 93.13 RHINORRHOEA | 2 0.02 93.15 RIGHT VENTRICULAR FAILURE | 1 0.01 93.16 ROUTINE HEALTH MAINTENANCE | 3 0.03 93.19 SALIVARY HYPERSECRETION | 1 0.01 93.20 SARCOMA | 1 0.01 93.21 SARCOMA METASTATIC | 1 0.01 93.22 SCAN WITH CONTRAST | 1 0.01 93.23 SCHIZOAFFECTIVE DISORDER | 6 0.06 93.29 SCHIZOPHRENIA | 61 0.61 93.90 SCHIZOPHRENIA, DISORGANISED TYPE | 1 0.01 93.91 SCHIZOPHRENIA, PARANOID TYPE | 5 0.05 93.96 SCIATICA | 3 0.03 93.99 SCLERODERMA | 4 0.04 94.03 SCOLIOSIS | 2 0.02 94.05 SEASONAL ALLERGY | 14 0.14 94.19 SECONDARY IMMUNODEFICIENCY | 1 0.01 94.20 SEDATION | 8 0.08 94.28 SEDATIVE THERAPY | 2 0.02 94.30 SELECTIVE IGG SUBCLASS DEFICIENCY | 1 0.01 94.31 SEPSIS | 6 0.06 94.37 SEPTIC SHOCK | 2 0.02 94.39 SERUM FERRITIN INCREASED | 1 0.01 94.40 SEVERE MENTAL RETARDATION | 1 0.01 94.41 SICKLE CELL ANAEMIA | 12 0.12 94.53 SINUS CONGESTION | 3 0.03 94.56 SINUS HEADACHE | 1 0.01 94.57 SINUS TACHYCARDIA | 1 0.01 94.58 SINUSITIS | 7 0.07 94.65 SJOGREN'S SYNDROME | 1 0.01 94.66 SKIN INFECTION | 1 0.01 94.67 SKIN PAPILLOMA | 1 0.01 94.68 SKIN ULCER | 3 0.03 94.71 SKIN WRINKLING | 1 0.01 94.72 SLEEP DISORDER | 40 0.40 95.12 SLEEP DISORDER THERAPY | 1 0.01 95.13 SMOKING CESSATION THERAPY | 27 0.27 95.40 SNEEZING | 1 0.01 95.41 SOFT TISSUE INFECTION | 1 0.01 95.42 SOMNAMBULISM | 1 0.01 95.43 SPINAL ANAESTHESIA | 3 0.03 95.46 SPINAL DISORDER | 1 0.01 95.47 SPINAL FRACTURE | 1 0.01 95.48 SPONDYLITIS | 1 0.01 95.49 SQUAMOUS CELL CARCINOMA | 2 0.02 95.51 STAPHYLOCOCCAL INFECTION | 3 0.03 95.54 STAPHYLOCOCCAL SEPSIS | 1 0.01 95.55 STATUS ASTHMATICUS | 1 0.01 95.56 STEM CELL TRANSPLANT | 9 0.09 95.65 STENT PLACEMENT | 14 0.14 95.79 STEROID THERAPY | 1 0.01 95.80 STOMATITIS | 4 0.04 95.84 STRABISMUS | 1 0.01 95.85 STREPTOCOCCAL INFECTION | 2 0.02 95.87 STRESS | 1 0.01 95.88 STRESS ECHOCARDIOGRAM | 1 0.01 95.89 SUBARACHNOID HAEMORRHAGE | 1 0.01 95.90 SUICIDE ATTEMPT | 12 0.12 96.02 SUPERINFECTION | 1 0.01 96.03 SUPPLEMENTATION THERAPY | 15 0.15 96.18 SUPPORTIVE CARE | 2 0.02 96.20 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.21 SURGERY | 3 0.03 96.24 SWEAT GLAND INFECTION | 1 0.01 96.25 SWELLING | 1 0.01 96.26 SYSTEMIC LUPUS ERYTHEMATOSUS | 12 0.12 96.38 SYSTEMIC SCLEROSIS | 1 0.01 96.39 T-CELL LYMPHOMA | 2 0.02 96.41 T-CELL LYMPHOMA STAGE IV | 4 0.04 96.45 TACHYCARDIA | 3 0.03 96.48 TACHYPHRENIA | 1 0.01 96.49 TARDIVE DYSKINESIA | 1 0.01 96.50 TEETHING | 11 0.11 96.61 TEMPORAL LOBE EPILEPSY | 1 0.01 96.62 TEMPOROMANDIBULAR JOINT SYNDROME | 1 0.01 96.63 TENDONITIS | 3 0.03 96.66 TENSION | 1 0.01 96.67 THERAPEUTIC PROCEDURE | 1 0.01 96.68 THROMBOCYTOPENIA | 5 0.05 96.73 THROMBOSIS | 1 0.01 96.74 THROMBOSIS PROPHYLAXIS | 25 0.25 96.99 THYROID DISORDER | 12 0.12 97.11 THYROIDECTOMY | 1 0.01 97.12 THYROIDITIS | 1 0.01 97.13 THYROXINE DECREASED | 1 0.01 97.14 TINEA PEDIS | 1 0.01 97.15 TOBACCO USER | 1 0.01 97.16 TONSILLITIS | 2 0.02 97.18 TOOTH EXTRACTION | 2 0.02 97.20 TOOTH INFECTION | 1 0.01 97.21 TOOTHACHE | 5 0.05 97.26 TORTICOLLIS | 2 0.02 97.28 TOXIC NODULAR GOITRE | 1 0.01 97.29 TOXOPLASMOSIS | 2 0.02 97.31 TRANSIENT ISCHAEMIC ATTACK | 3 0.03 97.34 TRANSITIONAL CELL CARCINOMA | 13 0.13 97.47 TRANSPLANT REJECTION | 1 0.01 97.48 TRAUMATIC BRAIN INJURY | 1 0.01 97.49 TREMOR | 5 0.05 97.54 TRIGEMINAL NEURALGIA | 4 0.04 97.58 TUBERCULIN TEST | 1 0.01 97.59 TUBERCULOSIS | 15 0.15 97.74 TUBERCULOSIS TEST POSITIVE | 1 0.01 97.75 TYPE 1 DIABETES MELLITUS | 18 0.18 97.93 TYPE 2 DIABETES MELLITUS | 90 0.90 98.83 ULCER | 3 0.03 98.86 UNEVALUABLE EVENT | 1 0.01 98.87 UPPER RESPIRATORY TRACT INFECTION | 7 0.07 98.94 URINARY INCONTINENCE | 6 0.06 99.00 URINARY RETENTION | 4 0.04 99.04 URINARY TRACT INFECTION | 16 0.16 99.20 URINE OUTPUT | 1 0.01 99.21 UROGRAM | 1 0.01 99.22 URTICARIA | 3 0.03 99.25 UTERINE CANCER | 3 0.03 99.28 UTERINE LEIOMYOMA | 3 0.03 99.31 UVEITIS | 1 0.01 99.32 VAGINAL CANCER | 1 0.01 99.33 VAGINAL DISCHARGE | 2 0.02 99.35 VARICELLA | 2 0.02 99.37 VASCULITIS | 4 0.04 99.41 VENA CAVA THROMBOSIS | 3 0.03 99.44 VENOUS THROMBOSIS | 1 0.01 99.45 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.46 VENTRICULAR TACHYCARDIA | 2 0.02 99.48 VISUAL ACUITY REDUCED | 2 0.02 99.50 VITAMIN SUPPLEMENTATION | 27 0.27 99.77 VOGT-KOYANAGI-HARADA SYNDROME | 1 0.01 99.78 VOMITING | 7 0.07 99.85 VULVITIS | 1 0.01 99.86 VULVOVAGINAL CANDIDIASIS | 1 0.01 99.87 VULVOVAGINAL DRYNESS | 2 0.02 99.89 WEGENER'S GRANULOMATOSIS | 3 0.03 99.92 WEIGHT CONTROL | 1 0.01 99.93 WEIGHT DECREASED | 2 0.02 99.95 WEIGHT LOSS DIET | 1 0.01 99.96 WHEEZING | 3 0.03 99.99 WOUND INFECTION STAPHYLOCOCCAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015